Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Debt to Equity (2020 - 2021)

PharmaCyte Biotech (PMCB) has disclosed Debt to Equity for 7 consecutive years, with $0.01 as the latest value for Q1 2021.

  • Quarterly Debt to Equity changed N/A to $0.01 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $0.01 through Jan 2021, changed N/A year-over-year, with the annual reading at $0.01 for FY2020, N/A changed from the prior year.
  • Debt to Equity for Q1 2021 was $0.01 at PharmaCyte Biotech, down from $0.02 in the prior quarter.
  • The five-year high for Debt to Equity was $0.02 in Q3 2020, with the low at $0.01 in Q1 2021.